Docetaxel (Taxotere): a new anti-cancer drug with promising potential?

Free PMC article

Editorial

J Verweij. Br J Cancer. 1994 Aug.

Free PMC article

. 1994 Aug;70(2):183-4.

doi: 10.1038/bjc.1994.276.

No abstract available

Comment on

Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study.
Sternberg CN, ten Bokkel Huinink WW, Smyth JF, Bruntsch V, Dirix LY, Pavlidis NA, Franklin H, Wanders S, Le Bail N, Kaye SB. Sternberg CN, et al. Br J Cancer. 1994 Aug;70(2):376-9. doi: 10.1038/bjc.1994.309. Br J Cancer. 1994. PMID: 7914427 Free PMC article. Clinical Trial.
Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.
Sulkes A, Smyth J, Sessa C, Dirix LY, Vermorken JB, Kaye S, Wanders J, Franklin H, LeBail N, Verweij J. Sulkes A, et al. Br J Cancer. 1994 Aug;70(2):380-3. doi: 10.1038/bjc.1994.310. Br J Cancer. 1994. PMID: 7914428 Free PMC article. Clinical Trial.
Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG).
Cerny T, Kaplan S, Pavlidis N, Schöffski P, Epelbaum R, van Meerbeek J, Wanders J, Franklin HR, Kaye S. Cerny T, et al. Br J Cancer. 1994 Aug;70(2):384-7. doi: 10.1038/bjc.1994.311. Br J Cancer. 1994. PMID: 7914429 Free PMC article. Clinical Trial.